Print

IPCAVD010

NCT02685020

Trial Details:

I Completed
Crucell Holland BV
Ad26.Mos.HIV Trivalent,gp140 C
Healthy adults
RandD/trials/Lists/ClinicalTrialsList
12/1/2017
Ad26.Mos.1.Env + Ad26.Mos1.Gag-Pol + Ad26.Mos2.Gag-Pol; Clade C gp140
Ad26.Mos.HIV vaccine at Week 0 and 12; followed by Ad26.Mos.HIV vaccine + Clade C glycoprotein 140 vaccine containing 250 microgram (mcg) of total protein mixed with adjuvant (aluminum phosphate) at Week 24 and 48 OR Ad26.Mos.HIV vaccine + Clade C glycopr